CHPA initiates search for president
This article was originally published in The Rose Sheet
Executive Summary
Consumer Healthcare Products Association is commencing search for a new president after Michael Maves, MD, was appointed to head American Medical Association Nov. 19. Maves will take over as AMA exec VP/CEO effective Jan. 15, departing CHPA after two years. Maves took the helm at CHPA not long after OTC trade group, formerly known as Nonprescription Drug Manufacturers Association, expanded its membership to include dietary supplement companies...
You may also be interested in...
CHPA interim president?
Consumer Healthcare Products Association reportedly offered board member and healthcare consultant Robert Donovan position of interim president. Donovan, who heads consultancy firm Robert Donovan LLC, formerly led consumer pharmaceuticals business at Sandoz Pharmaceuticals and also worked in consumer products division at Pfizer. He was first elected to CHPA board in 1990. If Donovan accepts, he will succeed Michael Maves, MD, who will leave the association Jan. 15 to head American Medical Association (1"The Rose Sheet" Nov. 26, In Brief)...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.